Sutro Biopharma, Inc. (STRO) Stock on a Consistently Rising Trajectory, Here’s the Reason

Sutro Biopharma, Inc. (STRO), a clinical-stage drug discovery, development, and manufacturing company, has surged 6.38% in the premarket trading session. Consequently, STRO stock is trading at $15.50 at the time of the writing. On Monday, the stock closed the day at $14.57 after gaining an increase of 2.25%. The consistent increase could be attributed to […]